Diosmin 900 mg + Hesperidin 100 mg
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus aurantium - fruit | 100 mg | Not calculated |
| 5-Hydroxy-2-(3-hydroxy-4-méthoxyphényl)-7-(O6-alpha-L-rhamnopyranosyl-bêta-D-glucopyranosyloxy)chromen-4-one Source : Citrus aurantium - fruit | 900 mg | Not calculated |
Non-medicinal ingredients
Gel de silice colloïdal, Lauryl sulfate de sodium, Oxyde de fer (Fe2O3), Oxyde de fer jaune, Gélatine, Stéarate de magnésium, Benzoate de sodium, Polacriline potassium, Talc, Poly(éthylène glycol), Phosphate de calcium, dibasique, Dioxyde de silicium colloïdal, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps relieve symptoms of non-complicated chronic venous insufficiency (CVI) such as sensation of swelling, varicose veins, feeling of heaviness, pain, tiredness and itching.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Cell DioHesp 1000 Tablets, Cell Diosmin-Hesperidin Tablets 1000 mg, Cell DiospHesp Tablets 1000 mg, Diosmin and Hesperidin Tablets 1000 mg
- Licence holder
- CellChem Pharmaceuticals Inc.
- NPN or DIN-HM
- 80127768
- Status
- Active licence
- Licence date
- 2 November 2023
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80127768
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Diosmin 900 mg + Hesperidin 100 mg (CellChem Pharmaceuticals Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80127768-diosmin-900-mg-hesperidin-100-mg, updated 2 November 2023.